Literature DB >> 9811293

Minocycline-related autoimmune hepatitis: case series and literature review.

J E Teitelbaum1, A R Perez-Atayde, M Cohen, A Bousvaros, M M Jonas.   

Abstract

BACKGROUND: Minocycline is an antibiotic commonly used in the treatment of adolescent acne.
OBJECTIVES: To describe the clinical, laboratory, and histological features in 3 cases of minocycline-related autoimmune hepatitis and to review the literature of similar cases in the adolescent population.
DESIGN: Case series.
SETTING: Patients were cared for in the Division of Gastroenterology, Children's Hospital, Boston, Mass.
RESULTS: Three adolescents (age, 15-16 years), while being treated with therapeutic doses of minocycline for periods of 12 to 20 months, met the 1993 International Autoimmune Hepatitis Group criteria for autoimmune hepatitis. All had a positive antinuclear antibody titer. Other features included hypergammaglobulinemia and a positive anti-smooth muscle antibody titer. Two patients underwent liver biopsy that revealed severe chronic lymphoplasmacytic inflammation, necrosis, and fibrosis. All other causes of liver disease were excluded. One patient had resolution of symptoms with withdrawal of the drug, while 2 required immunosuppression therapy. A review of the literature yielded only 18 similar cases, none in the pediatric literature, the majority of which contained incomplete pertinent data.
CONCLUSIONS: Minocycline is related to the development of autoimmune hepatitis in some adolescents. Pediatricians who use this drug for treatment of acne should be aware of this serious potential relation and stop the drug immediately when suspicion is raised.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9811293     DOI: 10.1001/archpedi.152.11.1132

Source DB:  PubMed          Journal:  Arch Pediatr Adolesc Med        ISSN: 1072-4710


  16 in total

1.  Drug-Induced Liver Disease.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-12

2.  Autoimmune hepatitis and thyroiditis associated with rifampin and pyrazinamide prophylaxis: an unusual reaction.

Authors:  Omar Khokhar; Christopher Gange; Stephen Clement; James Lewis
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

3.  Side effects of minocycline treatment in patients with fragile X syndrome and exploration of outcome measures.

Authors:  Agustini Utari; Weerasak Chonchaiya; Susan M Rivera; Andrea Schneider; Randi J Hagerman; Sultana M H Faradz; Iryna M Ethell; Danh V Nguyen
Journal:  Am J Intellect Dev Disabil       Date:  2010-09

4.  Liver damage associated with minocycline use in acne: a systematic review of the published literature and pharmacovigilance data.

Authors:  R A Lawrenson; H E Seaman; A Sundström; T J Williams; R D Farmer
Journal:  Drug Saf       Date:  2000-10       Impact factor: 5.606

5.  Two cases of food additive-induced severe liver damage associated with positive results on lymphocyte stimulation test and for antinuclear antibodies.

Authors:  Rena Kaneko; Chitose Ohishi; Miniru Kim; Masaaki Shiina; Satoshi Kusayanagi; Masazumi Ogawa; Kazuo Munakata; Kyoichi Mizuno; Yuzuru Sato
Journal:  Clin J Gastroenterol       Date:  2012-06-04

6.  Autoimmune hepatitis: the role of environmental risk factors: a population-based study.

Authors:  Jing H Ngu; Richard B Gearry; Chris M Frampton; Catherine A M Stedman
Journal:  Hepatol Int       Date:  2013-07-17       Impact factor: 6.047

Review 7.  Drug-induced liver injury in the elderly.

Authors:  Jonathan G Stine; Praveen Sateesh; James H Lewis
Journal:  Curr Gastroenterol Rep       Date:  2013-01

8.  Comprehensive behavioral testing in the R6/2 mouse model of Huntington's disease shows no benefit from CoQ10 or minocycline.

Authors:  Liliana B Menalled; Monica Patry; Natalie Ragland; Phillip A S Lowden; Jennifer Goodman; Jennie Minnich; Benjamin Zahasky; Larry Park; Janet Leeds; David Howland; Ethan Signer; Allan J Tobin; Daniela Brunner
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

Review 9.  Influence of genes, sex, age and environment on the onset of autoimmune hepatitis.

Authors:  Kathie Béland; Pascal Lapierre; Fernando Alvarez
Journal:  World J Gastroenterol       Date:  2009-03-07       Impact factor: 5.742

10.  Minocycline-Induced Autoimmune Hepatitis: A Rare But Important Cause of Drug-Induced Autoimmune Hepatitis.

Authors:  Elizabeth G Harmon; Randolph McConnie; Anil Kesavan
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2018-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.